1. Synthesis and Characterization of a Promising Novel FFAR1/GPR40 Targeting Fluorescent Probe for β-Cell Imaging
   Romain Bertrand et al, 2016, ACS Chem. Biol. CrossRef
2. Investigation of the Binding Interaction of Fatty Acids with Human G Protein-Coupled Receptor 40 Using a Site-Specific Fluorescence Probe by Flow Cytometry
   Xiao-Min Ren et al, 2016, Biochemistry CrossRef
3. Free Fatty Acid Receptors and Cancer: From Nutrition to Pharmacology.
   Mandi M. Hopkins et al, 2016 CrossRef
4. GPR40/FFA1 and neutral sphingomyelinase are involved in palmitate-boosted inflammatory response of microvascular endothelial cells to LPS
   Zhongyang Lu et al, 2015, Atherosclerosis CrossRef
5. Optical control of GPR40 signalling in pancreatic β-cells
   James Allen Frank et al, 2017, Chem. Sci. CrossRef
6. Inhibition of cholinergic potentiation of insulin secretion from pancreatic islets by chronic elevation of glucose and fatty acids: Protection by casein kinase 2 inhibitor
   Nicolai M. Doliba et al, 2017, Molecular Metabolism CrossRef
7. Therapeutic molecules against type 2 diabetes: What we have and what are we expecting?
   Ashwini Kumar et al, 2017, Pharmacological Reports CrossRef
8. Protective role of Pollen Typhae total flavone against the palmitic acid-induced impairment of glucose-stimulated insulin secretion involving GPR40 signaling in INS-1 cells
   Xiao-Tao Feng et al, 2017 CrossRef
9. G-protein coupled receptors (GPCRs) in the treatment of diabetes: Current view and future perspectives
   Guido Sebastiani et al, 2018, Best Practice & Research Clinical Endocrinology & Metabolism CrossRef
10. Postnatal differential expression of chemoreceptors of free fatty acids along the gastrointestinal tract of supplemental feeding v. grazing kid goats
    T. Ran et al, 2018, Animal CrossRef
11. Multitarget PPARγ agonists as innovative modulators of the metabolic syndrome
    Alessandra Ammazzalorso et al, 2019, European Journal of Medicinal Chemistry CrossRef
12. Mechanistic investigations of the liver toxicity of the free fatty acid receptor 1 agonist fasiglifam (TAK875) and its primary metabolites
    Timothy Ackerson et al, 2019, J Biochem Mol Toxicol CrossRef
13. Short Chain Fatty Acids, pancreatic dysfunction and type 2 diabetes
    Dipeeka K. Mandaliya et al, 2019, Pancreatology CrossRef
14. Involvement of G-Protein-Coupled Receptor 40 in the Inhibitory Effects of Docosahexaenoic Acid on SREBP1-Mediated Lipogenic Enzyme Expression in Primary Hepatocytes
    Seungtae On et al, 2019, IJMS CrossRef
15. An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseases
    Boon Chin Heng et al, 2013, Biotechnology Advances CrossRef
16. For Better or Worse: FFAR1 and FFAR4 Signaling in Cancer and Diabetes
    J. M. Houthuijzen, 2016, Mol Pharmacol CrossRef
17. GPR40 activation leads to CREB and ERK phosphorylation in primary cultures of neurons from the mouse CNS and in human neuroblastoma cells
    Marta Zamarbide et al, 2014, Hippocampus CrossRef
18. Synergistic antinociceptive effect and gastric safety of the combination of docosahexaenoic acid and indomethacin in rats
    Arlette Guadalupe Arroyo-Lira et al, 2014, Pharmacology Biochemistry and Behavior CrossRef
19. CNX-011-67, a novel GPR40 agonist, enhances glucose responsiveness, insulin secretion and islet insulin content in n-STZ rats and in islets from type 2 diabetic patients
    Venkategowda Sunil et al, 2014, BMC Pharmacol Toxicol CrossRef
20. G protein-coupled receptors in energy homeostasis
    Jue Wang et al, 2014, Sci. China Life Sci. CrossRef
21. QSAR study on 4-alkynyldihydrocinnamic acid analogs as free fatty acid receptor 1 agonists and antidiabetic agents: Rationales to improve activity
    null Rinnie et al, 2014, Arabian Journal of Chemistry CrossRef
22. Insulinotropic effect of Chikusetsu saponin IVa in diabetic rats and pancreatic β-cells
    Jia Cui et al, 2015, Journal of Ethnopharmacology CrossRef
23. Design, synthesis, and biological evaluation of novel thiazolidinediones as PPARγ/FFAR1 dual agonists
    Khaled M. Darwish et al, 2016, European Journal of Medicinal Chemistry CrossRef
24. Long-term safety and efficacy of fasiglifam (TAK-875), a G-protein-coupled receptor 40 agonist, as monotherapy and combination therapy in Japanese patients with type 2 diabetes: a 52-week open-label phase III study
    K. Kaku et al, 2016, Diabetes Obes Metab CrossRef
25. Exploration of phenylpropanoic acids as agonists of the free fatty acid receptor 4 (FFA4): Identification of an orally efficacious FFA4 agonist
    Steven M. Sparks et al, 2017, Bioorganic & Medicinal Chemistry Letters CrossRef
26. Cross-Talk Between Insulin Signaling and G Protein–Coupled Receptors
    Qin Fu et al, 2017, Journal of Cardiovascular Pharmacology CrossRef
27. Ginseng Gintonin Contains Ligands for GPR40 and GPR55
    Yeon-Jin Cho et al, 2020, Molecules CrossRef
28. Perfluorooctane sulfonate acute exposure stimulates insulin secretion via GPR40 pathway
    Lianying Zhang et al, 2020, Science of The Total Environment CrossRef
29. Ginseng gintonin, aging societies, and geriatric brain diseases
    Sun-Hye Choi et al, 2021, Integrative Medicine Research CrossRef
30. Inhibition of voltage-gated K+ channels mediates docosahexaenoic acid-stimulated insulin secretion in rat pancreatic β-cells
    Tao Bai et al, 2020, Food Funct. CrossRef
31. Olive Oil Lipophenols Induce Insulin Secretion in 832/13 β-Cell Models
    Maria Cristina Caroleo et al, 2021, Pharmaceutics CrossRef
32. Chlorogenic acid and β-glucan from highland barley grain ameliorate β-cell dysfunction via inhibiting apoptosis and improving cell proliferation
    Ze-Hua Liu et al, 2021, Food Funct. CrossRef
33. GPR40 agonist inhibits NLRP3 inflammasome activation via modulation of nuclear factor-κB and sarco/endoplasmic reticulum Ca2+-ATPase
    Jeongwoo Park et al, 2021, Life Sciences CrossRef
34. Recent Updates on Free Fatty Acid Receptor 1 (GPR-40) Agonists for the Treatment of Type 2 Diabetes Mellitus
    Lata Rani et al, 2021, MRMC CrossRef
35. Genetic Inactivation of Free Fatty Acid Receptor 3 Impedes Behavioral Deficits and Pathological Hallmarks in the APPswe Alzheimer’s Disease Mouse Model
    Marta Zamarbide et al, 2022, IJMS CrossRef
36. Oncogenic signaling of the Free-Fatty Acid Receptors FFA1 and FFA4 in human breast carcinoma cells
    Priyanka F. Karmokar et al, 2022, Biochemical Pharmacology CrossRef
37. The effects of GPR40 agonists on hair growth are mediated by ANGPTL4
    Doo Yeong Kim et al, 2023, Biomedicine & Pharmacotherapy CrossRef
38. Yiqi Huazhuo decoction increases insulin secretion in type 2 diabetic rats by regulating the pancreatic GPR40-IP3R-1 signaling pathway
    Dongjiao Wu et al, 2023, Front. Pharmacol. CrossRef
39. Exposure to per- and polyfluoroalkyl substances in early pregnancy, risk of gestational diabetes mellitus, potential pathways, and influencing factors in pregnant women: A nested case-control study
    Lu Zang et al, 2023, Environmental Pollution CrossRef
40. Cryo-electron microscopy for GPCR research and drug discovery in endocrinology and metabolism
    Jia Duan et al, 2024, Nat Rev Endocrinol CrossRef
41. Effects of Hypertriglyceridemia With or Without NEFA Elevation on β-cell Function and Insulin Clearance and Sensitivity
    Domenico Tricò et al, 2024 CrossRef
42. Exploring Druggable Binding Sites on the Class A GPCRs Using the Residue Interaction Network and Site Identification by Ligand Competitive Saturation
    Tugce Inan et al, 2024, ACS Omega CrossRef
43. GPR40 agonist ameliorates neurodegeneration and motor impairment by regulating NLRP3 inflammasome in Parkinson’s disease animal models
    Tae-Young Ha et al, 2024, Pharmacological Research CrossRef